 | • レポートコード：MRC2304F127 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、257ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本市場調査資料では、世界のラテラルフローアッセイ（LFA）市場規模が、2021年に5,760.08百万ドル、2022年に6,143.12百万ドルになり、その後CAGR 6.82％で成長して2027年までに8,560.83百万ドルに達すると予測しています。本書は、ラテラルフローアッセイ（LFA）の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（キット＆試薬、ラテラルフローリーダー）、技術別分析（競合アッセイ、マルチプレックス検出アッセイ、サンドイッチアッセイ）、サンプル種類別分析（血液サンプル、唾液サンプル、尿サンプル）、用途別分析（臨床試験、医薬品開発＆品質試験、食品安全＆環境試験、動物医療診断）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、本書内の企業情報には、Abbott Laboratories, Inc.、Abcam plc、Becton, Dickinson and Company、Bio-Rad Laboratories, Inc.、bioMérieux SA、BioPorto Diagnostics A/S、Chembio Diagnostic Systems, Inc.、Danaher Corporation、F. Hoffman-La Roche Ltd.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のラテラルフローアッセイ（LFA）市場規模：製品別 - キット＆試薬の市場規模 - ラテラルフローリーダーの市場規模 ・世界のラテラルフローアッセイ（LFA）市場規模：技術別 - 競合アッセイの市場規模 - マルチプレックス検出アッセイの市場規模 - サンドイッチアッセイの市場規模 ・世界のラテラルフローアッセイ（LFA）市場規模：サンプル種類別 - 血液サンプルの市場規模 - 唾液サンプルの市場規模 - 尿サンプルの市場規模 ・世界のラテラルフローアッセイ（LFA）市場規模：用途別 - 臨床試験における市場規模 - 医薬品開発＆品質試験における市場規模 - 食品安全＆環境試験における市場規模 - 動物医療診断における市場規模 ・世界のラテラルフローアッセイ（LFA）市場規模：地域別 - 南北アメリカのラテラルフローアッセイ（LFA）市場規模 アメリカのラテラルフローアッセイ（LFA）市場規模 カナダのラテラルフローアッセイ（LFA）市場規模 ブラジルのラテラルフローアッセイ（LFA）市場規模 ... - アジア太平洋のラテラルフローアッセイ（LFA）市場規模 日本のラテラルフローアッセイ（LFA）市場規模 中国のラテラルフローアッセイ（LFA）市場規模 インドのラテラルフローアッセイ（LFA）市場規模 韓国のラテラルフローアッセイ（LFA）市場規模 台湾のラテラルフローアッセイ（LFA）市場規模 ... - ヨーロッパ/中東/アフリカのラテラルフローアッセイ（LFA）市場規模 イギリスのラテラルフローアッセイ（LFA）市場規模 ドイツのラテラルフローアッセイ（LFA）市場規模 フランスのラテラルフローアッセイ（LFA）市場規模 ロシアのラテラルフローアッセイ（LFA）市場規模 ... - その他地域のラテラルフローアッセイ（LFA）市場規模 ・競争状況 ・企業情報 |
The Global Lateral Flow Assays Market size was estimated at USD 5,760.08 million in 2021 and expected to reach USD 6,143.12 million in 2022, and is projected to grow at a CAGR 6.82% to reach USD 8,560.83 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Lateral Flow Assays to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Kits & Reagents and Lateral Flow Readers. The Lateral Flow Readers is further studied across Benchtop Readers, Digital/Handheld Readers, and Mobile/Smartphone Readers.
Based on Technique, the market was studied across Competitive Assays, Multiplex Detection Assays, and Sandwich Assays.
Based on Sample Type, the market was studied across Blood Samples, Saliva Samples, and Urine Samples.
Based on Application, the market was studied across Clinical Testing, Drug Development & Quality Testing, Food Safety & Environment Testing, and Veterinary Diagnostics. The Clinical Testing is further studied across Cardiac Marker Testing, Cholesterol Testing/Lipid Profiles, Drugs-of-Abuse Testing, Infectious Disease Testing, and Pregnancy & Fertility Testing. The Cardiac Marker Testing is further studied across BNP or NT-proBNP Testing, CK-MB Testing, D-Dimer Testing, Myoglobin Testing, Other Cardiac Markers, and Troponin I & T Testing. The Infectious Disease Testing is further studied across Covid-19, Hepatitis, Influenza, Mosquito-borne Diseases, Sexually Transmitted Infections, and Tuberculosis. The Sexually Transmitted Infections is further studied across Chlamydia, Gonorrhea, HIV, HPV, and Syphilis. The Pregnancy & Fertility Testing is further studied across Fertility Testing and Pregnancy Testing.
Based on End-User, the market was studied across Diagnostic Laboratories, Home Care Settings, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Lateral Flow Assays market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Lateral Flow Assays Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Lateral Flow Assays Market, including Abbott Laboratories, Inc., Abcam plc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, BioPorto Diagnostics A/S, Chembio Diagnostic Systems, Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., Hologic Inc., Merck KGaA, Microcoat Biotechnologie GmbH, OraSure Technologies, Inc., PerkinElmer Inc., Polysciences, Inc., QIAGEN N.V, Quidel Corporation, Siemens AG, Surmodics IVD, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Lateral Flow Assays Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Lateral Flow Assays Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Lateral Flow Assays Market?
4. What is the competitive strategic window for opportunities in the Global Lateral Flow Assays Market?
5. What are the technology trends and regulatory frameworks in the Global Lateral Flow Assays Market?
6. What is the market share of the leading vendors in the Global Lateral Flow Assays Market?
7. What modes and strategic moves are considered suitable for entering the Global Lateral Flow Assays Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing usage of home-based lateral flow assay devices
5.1.1.2. High prevalence of infectious diseases across the globe
5.1.1.3. Rapidly increasing demand for point-of-care testing
5.1.2. Restraints
5.1.2.1. Lower accuracy of lateral flow assay tests
5.1.3. Opportunities
5.1.3.1. Technological advancements in lateral flow assays
5.1.3.2. Evolving applications of lateral flow assays
5.1.3.3. Rising demand for lateral flow assays in the food & beverage industry
5.1.4. Challenges
5.1.4.1. Limited reimbursements for lateral flow assay products
5.2. Cumulative Impact of COVID-19
6. Lateral Flow Assays Market, by Product
6.1. Introduction
6.2. Kits & Reagents
6.3. Lateral Flow Readers
6.4.1. Benchtop Readers
6.4.2. Digital/Handheld Readers
6.4.3. Mobile/Smartphone Readers
7. Lateral Flow Assays Market, by Technique
7.1. Introduction
7.2. Competitive Assays
7.3. Multiplex Detection Assays
7.4. Sandwich Assays
8. Lateral Flow Assays Market, by Sample Type
8.1. Introduction
8.2. Blood Samples
8.3. Saliva Samples
8.4. Urine Samples
9. Lateral Flow Assays Market, by Application
9.1. Introduction
9.2. Clinical Testing
9.3.1. Cardiac Marker Testing
9.3.2.1. BNP or NT-proBNP Testing
9.3.2.2. CK-MB Testing
9.3.2.3. D-Dimer Testing
9.3.2.4. Myoglobin Testing
9.3.2.5. Other Cardiac Markers
9.3.2.6. Troponin I & T Testing
9.3.2. Cholesterol Testing/Lipid Profiles
9.3.3. Drugs-of-Abuse Testing
9.3.4. Infectious Disease Testing
9.3.5.1. Covid-19
9.3.5.2. Hepatitis
9.3.5.3. Influenza
9.3.5.4. Mosquito-borne Diseases
9.3.5.5. Sexually Transmitted Infections
9.3.5.6.1. Chlamydia
9.3.5.6.2. Gonorrhea
9.3.5.6.3. HIV
9.3.5.6.4. HPV
9.3.5.6.5. Syphilis
9.3.5.6. Tuberculosis
9.3.5. Pregnancy & Fertility Testing
9.3.6.1. Fertility Testing
9.3.6.2. Pregnancy Testing
9.3. Drug Development & Quality Testing
9.4. Food Safety & Environment Testing
9.5. Veterinary Diagnostics
10. Lateral Flow Assays Market, by End-User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care Settings
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies
11. Americas Lateral Flow Assays Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Lateral Flow Assays Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Lateral Flow Assays Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Abcam plc
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Becton, Dickinson and Company
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bio-Rad Laboratories, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. bioMérieux SA
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. BioPorto Diagnostics A/S
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Chembio Diagnostic Systems, Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Danaher Corporation
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. F. Hoffman-La Roche Ltd.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Hologic Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Merck KGaA
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Microcoat Biotechnologie GmbH
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. OraSure Technologies, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. PerkinElmer Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Polysciences, Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. QIAGEN N.V
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Quidel Corporation
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Siemens AG
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Surmodics IVD
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Thermo Fisher Scientific, Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing